Autologous HIV vaccine - BioDelivery Sciences
Alternative Names: HIV/cellular vaccine - BioDelivery SciencesLatest Information Update: 24 Mar 2022
At a glance
- Originator BioDelivery Sciences International
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 22 Mar 2022 BioDelivery Sciences International has been acquired by Collegium Pharmaceutical
- 12 Feb 2003 Phase-I/II clinical trials in HIV infections treatment in USA (IM)